SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-04-060245
Filing Date
2004-12-21
Accepted
2004-12-21 18:41:44
Documents
1
Period of Report
2004-12-17

Document Format Files

Seq Description Document Type Size
1 rrd62117.html 3  
1 rrd62117.xml 3 3309
  Complete submission text file 0001181431-04-060245.txt   5233
Mailing Address 401 WILSHIRE BOULEVARD SUITE 1020 SANTA MONICA CA 90401
Business Address 401 WILSHIRE BOULEVARD SUITE 1020 SANTA MONICA CA 90401 310-526-5000
ORION ACQUISITION CORP II (Issuer) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 167 SKYVIEW WAY SAN FRANCISCO CA 94131
Business Address 167 SKYVIEW WAY SAN FRANCISCO CA 94131 4159904761
Selena Pharmeceuticals Inc (Reporting) CIK: 0001311211 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-20837 | Film No.: 041218742